EPRX Competitors & Alternatives
Compare Eupraxia Pharmaceuticals Inc. Common Stock with similar stocks in the same industry
Pharmaceutical Preparations
EPRX
Main Stock$8.64
Tradestie Score
57
Market Cap
$307.12M
Analyst Upside
+66.7%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1094.88
|
$739.95B | 51.3 | 58 | Compare |
|
JNJ
Johnson & Johnson
|
$234.42
|
$448.07B | 20.9 | 65 | Compare |
|
ABBV
ABBVIE INC.
|
$210.56
|
$431.71B | 169.7 | 62 | Compare |
|
NVO
Novo-Nordisk A/S
|
$47.65
|
$262.92B | 15.9 | 50 | Compare |
|
AZN
AstraZeneca PLC
|
$188.72
|
$261.56B | 62.6 | 61 | Compare |
|
NVS
Novartis AG
|
$153.13
|
$254.99B | 20.7 | 67 | Compare |
|
ABT
Abbott Laboratories
|
$108.75
|
$232.30B | 29.4 | 62 | Compare |
|
MRK
Merck & Co., Inc.
|
$119.65
|
$225.13B | 15.0 | 66 | Compare |
|
PFE
Pfizer Inc.
|
$26.62
|
$154.70B | 15.5 | 66 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$48.28
|
$121.27B | 19.7 | 57 | Compare |
More EPRX Analysis
Data updated: Feb 04, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry